You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immune persistence

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rabies, Antibody Trial in Changchun (5 doses program)

Completed
  • Rabies
  • Antibody
  • 5 doses program
  • Changchun, Jilin, China
    Changchun Zhuoyi Biological Co., Ltd
Sep 18, 2022

After Whole Vaccination Shcedule With Recombination Quadrivalent

Not yet recruiting
  • HPV Infections
  • +6 more
    • (no location specified)
    May 7, 2022

    Hand, Foot and Mouth Disease Trial (EV71 Vaccine)

    Not yet recruiting
    • Hand, Foot and Mouth Disease
    • EV71 Vaccine
    • (no location specified)
    Nov 17, 2023

    COVID-19, HIV Trial in Hangzhou (Inactivated COVID-19 vaccine)

    Not yet recruiting
    • COVID-19
    • HIV Infections
    • Inactivated COVID-19 vaccine
    • Hangzhou, Zhejiang, China
      Zhejiang provincial center for disease control and prevention
    Oct 22, 2021

    COVID-19, Chronic Bronchitis, COPD Trial in Hangzhou (Inactivated COVID-19 vaccine)

    Not yet recruiting
    • COVID-19
    • +2 more
    • Inactivated COVID-19 vaccine
    • Hangzhou, Zhejiang, China
      Zhejiang provincial center for disease control and prevention
    Oct 21, 2021

    COVID-19 Pandemic Trial in Vientiane (COVID-19 mRNA vaccine)

    Recruiting
    • COVID-19 Pandemic
    • COVID-19 mRNA vaccine
    • Vientiane, Lao People's Democratic Republic
      Mayfong Mayxay
    Mar 2, 2022

    Chronic Rhinosinusitis With Nasal Polyps Trial in Vancouver (Mepolizumab)

    Not yet recruiting
    • Chronic Rhinosinusitis With Nasal Polyps
    • Vancouver, British Columbia, Canada
      St. Paul's Sinus Centre
    Oct 24, 2023

    Long COVID-19, Long COVID Trial (Paxlovid 25 day dosing, Paxlovid 15 day dosing, Control)

    Not yet recruiting
    • Long COVID-19
    • Long COVID
    • Paxlovid 25 day dosing
    • +2 more
    • (no location specified)
    Jul 25, 2023

    Meningococcal Infection Trial in Santiago de Compostela, Madrid, Sevilla (Meningococcal Polysaccharide (Serogroups A, C, W, and

    Recruiting
    • Meningococcal Infection
    • Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine
    • Budapest, Hungary
    • +5 more
    Sep 15, 2022

    Immune Memory of Inactivated COVID-19 Vaccine

    Completed
    • COVID-19
      • Beijing, China
        Beijing Center for Disease Control and Prevention
      Oct 8, 2021

      COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in

      Not yet recruiting
      • Follicular Lymphoma
      • Cellular immunity vs SARS-CoV-2
      • +6 more
      • Alessandria, IT, Italy
      • +13 more
      Oct 10, 2023

      Herpes Zoster Trial in Tartu (HZ/su vaccine)

      Recruiting
      • Herpes Zoster
      • HZ/su vaccine
      • Elkridge, Maryland
      • +47 more
      Jan 6, 2023

      Hepatitis B Trial in Bangkok, Khon Kaen (Euvax B®: Hepatitis B vaccine)

      Completed
      • Hepatitis B
      • Euvax B®: Hepatitis B vaccine
      • Bangkok, Thailand
      • +1 more
      Mar 28, 2022

      HIV Persistence in Lymph Node and Peripheral Blood

      Completed
      • HIV-1-infection
      • Leukapheresis
      • Lymph node biopsy
      • Melbourne, Victoria, Australia
        Alfred Hospital
      Jun 22, 2021

      Poliomyelitis, Vaccine Reaction Trial (Eupolio)

      Not yet recruiting
      • Poliomyelitis
      • Vaccine Reaction
      • Eupolio
      • (no location specified)
      Jun 23, 2022

      Pneumococcal Infections, HIV Trial (PPV-23 Vaccine, PCV-13 Vaccine, Placebo Vaccine)

      Withdrawn
      • Pneumococcal Infections
      • HIV Infections
      • PPV-23 Vaccine
      • +2 more
      • (no location specified)
      Oct 28, 2021

      Coronavirus Disease 2019 Trial in Buenos Aires (serology)

      Completed
      • Coronavirus Disease 2019
      • serology
      • Buenos Aires, Ciudad De Buenos Aires, Argentina
        Hospital de Niños Ricardo Gutierrez
      Aug 23, 2021

      Cervical Intraepithelial Neoplasia Trial in Taizhou (Blood sampling for antibody determination)

      Completed
      Has Results
      • Cervical Intraepithelial Neoplasia
      • Blood sampling for antibody determination
      • Taizhou, Jiangsu, China
        GSK Investigational Site
      Oct 27, 2020

      Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers

      Completed
      Has Results
      • Pneumococcal Disease
        • Kisumu, Kenya
          Kenya Medical Research Institute/Walter Reed Project
        Feb 3, 2020

        Hepatitis A Trial in Changzhou (Healive® Lot 1, Healive® Lot 2, Healive® Lot 3)

        Completed
        • Hepatitis A
        • Healive® Lot 1
        • +3 more
        • Changzhou, Jiangsu, China
          Changzhou City Center for Disease Control and Prevention
        Aug 29, 2019

        After Immunisation With Ebola Virus Vaccines

        Completed
        • Ebola Virus Disease
        • Previously exposed to Ebola vaccine
        • Glasgow, United Kingdom
        • +1 more
        Jul 14, 2020

        Consequences of Poly Vaccination on Innate Immunity :

        Not yet recruiting
        • Vaccine Breakthrough Infections
        • Blood and saliva sampling
        • Survey
        • (no location specified)
        Oct 26, 2023

        Two Domestic HPV Vaccines and Imported HPV Vaccines in Women

        Not yet recruiting
        • HPV Infection
        • +2 more
        • Follow up
        • Fuzhou, Fujian, China
          Fujian Maternity and Child Health Hospital
        Nov 16, 2023

        COVID-19 Trial in Chengdu (LYB002V14, LYB002V14A, LYB002CA)

        Active, not recruiting
        • COVID-19
        • LYB002V14
        • +2 more
        • Chengdu, Sichuan, China
          Affiliated Hospital of North Sichuan MedicalCollege
        Jun 29, 2023

        COVID-19 Trial in Weihai (Inactivated COVID-19 Vaccine)

        Active, not recruiting
        • COVID-19
        • Inactivated COVID-19 Vaccine
        • Weihai, Shandong, China
          Rushan City Center for Disease Control and Prevention
        Jul 11, 2022